Clinical Trial Update: Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a study of cordycepin plus pentostatin in patients with refractory TdT-positive leukemia (Phase 1/Phase 2); current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Cordycepin (cordycepin)
• Pentostatin (pentostatin)

Snippet

Sponsor: OncoVista, Inc. | Conditions: Refractory TdT-Positive Leukemia | Phase 1, Phase 2 | Status: UNKNOWN